Chiba, Japan

Teruo Koumoto

This inventor holds 2 USPTO granted patents. Top assignee: Ss Pharmaceutical Co., Ltd.. Active years: 1987.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Teruo Koumoto: Innovator in Pharmaceutical Chemistry

Introduction

Teruo Koumoto is a distinguished inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on 1,7-naphthyridine derivatives. With a total of 2 patents, Koumoto's inventions have the potential to address various medical conditions.

Latest Patents

Koumoto's latest patents include "1,7-Naphthyridine derivatives and medicinal preparations containing same" and "1,7-Naphthyridine derivatives and pharmaceutical compositions." These patents describe certain 1,7-naphthyridine derivatives and their acid addition salts, which exhibit strong anticholinergic, cardiotonic, diuretic, bronchodilation, anti-acetylcholine, anti-inflammatory, and analgesic effects. These compounds are useful in treating a range of diseases, including heart diseases, hypertension, asthma, arthritis, lumbago, and toothache.

Career Highlights

Koumoto is currently associated with Ss Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic applications in medicine.

Collaborations

Throughout his career, Koumoto has collaborated with notable colleagues, including Susumu Sato and Haruyoshi Honda. These partnerships have contributed to the success of his research and the development of innovative pharmaceutical solutions.

Conclusion

Teruo Koumoto's contributions to pharmaceutical chemistry, particularly through his patents on 1,7-naphthyridine derivatives, highlight his role as a key innovator in the field. His work promises to enhance treatment options for various medical conditions, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…